Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practice

    loading  Checking for direct PDF access through Ovid


Although the causal relationship between apolipoprotein-B (apoB) containing lipoproteins, particularly LDL, and atherosclerotic vascular disease has been amply reinforced by recent trials [1▪], interventions to raise HDL have proved ineffective in lowering Cardiovascular disease (CVD) risk, and in some cases, problematic due to potentially harmful adverse actions.
    loading  Loading Related Articles